These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7248483)

  • 1. Estimation of the systemic bioavailability of timolol in man.
    El-Rashidy R
    Biopharm Drug Dispos; 1981; 2(2):197-202. PubMed ID: 7248483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timolol and propranolol: bioavailability, plasma concentrations, and beta blockade.
    Wilson TW; Firor WB; Johnson GE; Holmes GI; Tsianco MC; Huber PB; Davies RO
    Clin Pharmacol Ther; 1982 Dec; 32(6):676-85. PubMed ID: 7140133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacologic observations on timolol. I. Disposition and effect in relation to plasma level in normal individuals.
    Ishizaki T; Tawara K; Oyama Y; Nakaya H
    J Clin Pharmacol; 1978; 18(11-12):511-8. PubMed ID: 721948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.
    Ishizaki T; Tawara K
    Eur J Clin Pharmacol; 1978 Nov; 14(1):7-14. PubMed ID: 32043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral timolol studied by mass fragmentography.
    Fourtillan JB; Courtois P; Lefebvre MA; Girault J
    Eur J Clin Pharmacol; 1981 Feb; 19(3):193-6. PubMed ID: 7215417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems.
    Herbette L; Katz AM; Sturtevant JM
    Mol Pharmacol; 1983 Sep; 24(2):259-69. PubMed ID: 6888369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of the beta-adrenergic blocking agents propranolol and timolol by rodent brain: relationship to central pharmacological actions.
    Tocco DJ; Clineschmidt BV; Duncan AE; deLuna FA; Baer JE
    J Cardiovasc Pharmacol; 1980; 2(2):133-43. PubMed ID: 6171681
    [No Abstract]   [Full Text] [Related]  

  • 8. Absorption of ocular timolol.
    Alvan G; Calissendorff B; Seideman P; Widmark K; Widmark G
    Clin Pharmacokinet; 1980; 5(1):95-100. PubMed ID: 7363532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of timolol in man.
    Vermeij P; el-Sherbini-Schepers M; van Zwieten PA
    J Pharm Pharmacol; 1978 Jan; 30(1):53-5. PubMed ID: 22728
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic differences between single and multiple oral dosing with the guidance for beta-adrenoceptor blockade assessment.
    Ishizaki T; Tawara K
    Cardiology; 1979; 64 Suppl 1():25-43. PubMed ID: 42487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.
    Mäntylä R; Männistö P; Nykänen S; Koponen A; Lamminsivu U
    Eur J Clin Pharmacol; 1983; 24(2):227-30. PubMed ID: 6840172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific binding of timolol, a beta-adrenergic blocking agent.
    Tocco DJ; Hooke KF; Deluna FA; Duncan AE
    Drug Metab Dispos; 1976; 4(4):323-9. PubMed ID: 8286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers.
    Vedin JA; Kristianson JK; Wilhelmsson CE
    Eur J Clin Pharmacol; 1982; 23(1):43-7. PubMed ID: 7128671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active transport of beta-adrenergic blocking agents in the anterior uvea of albino rabbit.
    Matsumoto S; Araie M; Takase M
    Jpn J Ophthalmol; 1986; 30(4):339-50. PubMed ID: 2884338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM; Kaila T; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timolol kinetics in chronic renal insufficiency.
    Lowenthal DT; Pitone JM; Affrime MB; Shirk J; Busby P; Kim KE; Nancarrow J; Swartz CD; Onesti G
    Clin Pharmacol Ther; 1978 May; 23(5):606-15. PubMed ID: 639436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol metabolism in man and laboratory anamals.
    Tocco DJ; Duncan AE; deLuna FA; Smith JL; Walker RW; Vandenheuvel WJ
    Drug Metab Dispos; 1980; 8(4):236-40. PubMed ID: 6105057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic blockers. Choosing among them.
    Vlietstra RE; McGoon MD
    Postgrad Med; 1984 Sep; 76(3):71-3, 76-7, 80. PubMed ID: 6147832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma timolol levels after oral and intravenous administration.
    Else OF; Sorenson H; Edwards IR
    Eur J Clin Pharmacol; 1978 Dec; 14(6):431-4. PubMed ID: 738350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.